Reaktionsgleichung
[CH3:1][C:2]1[CH:19]=[CH:18][C:5]([NH:6][C:7]2[S:8][C:9]3[N:17]=[CH:16][CH:15]=[CH:14][C:10]=3[C:11](=[O:13])[N:12]=2)=[CH:4][CH:3]=1.[H-].[Li+].[CH3:22]I>>[CH3:22][N:12]1[C:11](=[O:13])[C:10]2[CH:14]=[CH:15][CH:16]=[N:17][C:9]=2[S:8][C:7]1=[N:6][C:5]1[CH:18]=[CH:19][C:2]([CH3:1])=[CH:3][CH:4]=1Komponenten
4
Versuchsvorschrift
The reaction procedure of Example 11 was followed except that 949 mg (3.52 mmol) of 2-(4-methylanilino)-4H-pyrido[3,2-e]-1,3-thiazin-4-one, 28 mg of lithium hydride and 500 mg of methyl iodide were used. The resulting residue was then purified through silica gel column chromatography (eluant: chloroform) to obtain 698 mg of 2,3-dihydro-3-methyl-2-[(4-methylphenyl)imino]-4H-pyrido[3,2-e]-1,3-thiazin-4-one (70%, recrystallized from a mixture of ether and hexane).
Aufarbeitung
- customThe reaction procedure of Example 11
- customThe resulting residue was then purified through silica gel column chromatography (eluant: chloroform)
Quellen und Nachweise
- ORD-Eintrag
- ord-ba8b247d9da745d082106593cfb92802
- Quelldatensatz
- uspto-grants-2000_10
- Patentnummer
- US06133258
Verknüpfte Notizen
Wird geladen…